Cargando…

Correcting for multiple-testing in multi-arm trials: is it necessary and is it done?

BACKGROUND: Multi-arm trials enable the evaluation of multiple treatments within a single trial. They provide a way of substantially increasing the efficiency of the clinical development process. However, since multi-arm trials test multiple hypotheses, some regulators require that a statistical cor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wason, James M S, Stecher, Lynne, Mander, Adrian P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177585/ https://www.ncbi.nlm.nih.gov/pubmed/25230772 http://dx.doi.org/10.1186/1745-6215-15-364

Ejemplares similares

An optimised multi-arm multi-stage clinical trial design for unknown variance
por: Grayling, Michael J., et al.
Publicado: (2018)

Optimal design for multi-arm multi-stage clinical trials
por: Wason, James MS, et al.
Publicado: (2011)

Some recommendations for multi-arm multi-stage trials
por: Wason, James, et al.
Publicado: (2012)

The choice of test in phase II cancer trials assessing continuous tumour shrinkage when complete responses are expected
por: Wason, James MS, et al.
Publicado: (2015)

Exact group sequential designs for two-arm experiments with Poisson distributed outcome variables
por: Grayling, Michael J., et al.
Publicado: (2021)

A comparison of bayesian adaptive randomization and multi-stage designs for multi-arm clinical trials
por: Wason, James, et al.
Publicado: (2013)

A web application for the design of multi-arm clinical trials
por: Grayling, Michael J., et al.
Publicado: (2020)

A multi-stage drop-the-losers design for multi-arm clinical trials
por: Wason, James, et al.
Publicado: (2016)

Familywise error control in multi‐armed response‐adaptive trials
por: Robertson, D. S., et al.
Publicado: (2019)

Multi-arm multi-stage trials can improve the efficiency of finding effective treatments for stroke: a case study
por: Jaki, Thomas, et al.
Publicado: (2018)

Minimizing the Maximum Expected Sample Size in Two-Stage Phase II Clinical Trials with Continuous Outcomes
por: Wason, James M. S., et al.
Publicado: (2012)

Revisiting the multi-armed bandit model for the optimal design of clinical trials: benefits and drawbacks
por: Villar, Sofia S, et al.
Publicado: (2013)

Designing Multi-arm Multistage Adaptive Trials for Neuroprotection in Progressive Multiple Sclerosis
por: Li, Vivien, et al.
Publicado: (2022)

Stepped-wedge cluster randomised trials: where, when and why?
por: Grayling, Michael, et al.
Publicado: (2015)

Controlling type I error rates in multi-arm clinical trials: A case for the false discovery rate
por: Wason, James M. S., et al.
Publicado: (2021)

Admissible multiarm stepped‐wedge cluster randomized trial designs
por: Grayling, Michael J., et al.
Publicado: (2018)

Blinded and unblinded sample size reestimation in crossover trials balanced for period
por: Grayling, Michael J., et al.
Publicado: (2018)

Group sequential crossover trial designs with strong control of the familywise error rate
por: Grayling, Michael J., et al.
Publicado: (2018)

Blinded and unblinded sample size reestimation procedures for stepped‐wedge cluster randomized trials
por: Grayling, Michael J., et al.
Publicado: (2018)

Optimal multistage designs for randomised clinical trials with continuous outcomes
por: Wason, James MS, et al.
Publicado: (2012)

Group sequential designs for stepped-wedge cluster randomised trials
por: Grayling, Michael J, et al.
Publicado: (2017)

Stepped wedge cluster randomized controlled trial designs: a review of reporting quality and design features
por: Grayling, Michael J., et al.
Publicado: (2017)

Designs for adding a treatment arm to an ongoing clinical trial
por: Bennett, Maxine, et al.
Publicado: (2020)

Planning multi-arm screening studies within the context of a drug development program
por: Wason, James M S, et al.
Publicado: (2013)

An adaptive trial design for updating the threshold of a continuous biomarker
por: Spencer, Amy, et al.
Publicado: (2015)

Two-Stage Single-Arm Trials Are Rarely Analyzed Effectively or Reported Adequately
por: Grayling, Michael J., et al.
Publicado: (2021)

Do single‐arm trials have a role in drug development plans incorporating randomised trials?
por: Grayling, Michael J., et al.
Publicado: (2015)

Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials
por: Mossop, Helen, et al.
Publicado: (2021)

Re-formulating Gehan’s design as a flexible two-stage single-arm trial
por: Grayling, Michael J., et al.
Publicado: (2019)

Non-adjustment for multiple testing in multi-arm trials of distinct treatments: Rationale and justification
por: Parker, Richard A, et al.
Publicado: (2020)

A stochastically curtailed single-arm phase II trial design for binary outcomes
por: Law, Martin, et al.
Publicado: (2022)

Baseline testing in cluster randomised controlled trials: should this be done?
por: Bolzern, Jaime E., et al.
Publicado: (2019)

A stochastically curtailed two-arm randomised phase II trial design for binary outcomes
por: Law, Martin, et al.
Publicado: (2021)

Good Work Done, and to Be Done
Publicado: (1886)

Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta-Analysis
por: Tolkien, Zoe, et al.
Publicado: (2015)

Multiple HIV testing strategies are necessary to end AIDS
por: Sanders, Eduard J., et al.
Publicado: (2021)

Not everything that can be done should be done
por: Slagt, Cor
Publicado: (2016)

Factorial versus multi‐arm multi‐stage designs for clinical trials with multiple treatments
por: Jaki, Thomas, et al.
Publicado: (2016)

Defibrillation test in paediatric patients: should be done?
por: Sarquella Brugada, G
Publicado: (2023)

Well Done, Montana! Well Done, Knowles!
Publicado: (1901)

Cannot write session to /tmp/vufind_sessions/sess_kko4tcehncpvm8gdbnv4qra69p